PharmaCyte Biotech, Inc. (Nasdaq: PMCB) announced today that its Board of Directors has authorized a second share repurchase program to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE